Childhood rhabdomyosarcoma xenografts: Responses to DNA-interacting agents and agents used in current clinical therapy
- 1 July 1984
- journal article
- research article
- Published by Elsevier in European Journal of Cancer and Clinical Oncology
- Vol. 20 (7) , 955-960
- https://doi.org/10.1016/0277-5379(84)90170-6
Abstract
No abstract availableThis publication has 26 references indexed in Scilit:
- The comparative pharmacokinetics of pentamethylmelamine in man, rat, and mouseCancer Chemotherapy and Pharmacology, 1982
- A Prospective Screening Program: Current Screening and its StatusPublished by Springer Nature ,1981
- Cross resistance between actinomycin-D, adriamycin and vincristine in a murine solid tumour in vivoBiochemical Pharmacology, 1980
- Progress and controversy in the treatment of childhood rhabdomyosarcomaCancer Treatment Reviews, 1978
- Combination chemotherapy with adriamycin (NSC‐123127) and dimethyl triazeno imidazole carboxamide (DTIC) (NSC‐45388) in children with metastatic solid tumorsMedical and Pediatric Oncology, 1976
- Incidence of malignant tumors in U.S. childrenThe Journal of Pediatrics, 1975
- Reduced permeability in CHO cells as a mechanism of resistance to colchicineJournal of Cellular Physiology, 1974
- Cyclophosphamide Treatment for Metastatic Soft Tissue SarcomaAmerican Journal of Diseases of Children, 1967
- Vincristine in children with malignant solid tumorsThe Journal of Pediatrics, 1964
- CLINICAL STUDIES OF ACTINOMYCIN D WITH SPECIAL REFERENCE TO WILMS' TUMOR IN CHILDREN*Annals of the New York Academy of Sciences, 1960